In June 2024, Boai NKY Medical Holdings Ltd. (NKY Group) announced that it has been approved by United Nations Global Compact (UNGC), officially joined the UNGC. NKY Group is committed to support the UNGC's ten principles on human rights, Labour, environment and anti-corruption, apply the ten principles more broadly to future business activities, and report regularly on progress.

From 5th to 7th of April, 2022, BOAI NKY PHARMACEUTICALS LTD., a subsidiary company of Boai NKY Medical Holdings Ltd. (Stock Code: 300109), took part in the “in-cosmetics®Global” global personal cosmetics raw materials exhibition with a few new products. In this event, NKY released three new co-polymer products: PoliRez®, Nokesho® and DermaRez®, in which DermaRez® is a raw material product NKY has developed for skin care application. These new products launched this time enrich the variety of NKY products and provide customers of NKY with more options. Get to know NKY State-of-the-art production facilityGlobal supply with local (safety) stockDedicated customer service & supportStrong quality management systemFocused environmental awarenessPartnered product developmentTransparent communicationContinuous investmentCustomer base representing SMEs to MNCs The right choice for new product development and sourcing of your PVP and PVM/MA commercial products.

In-Cosmetics Global 2019 was held in Paris on April, 2nd, 2019.Focus more on customer service and product innovationA new R&D centre with occupied area of 6200 ㎡ has been put into operation at headquarter of Boai NKY which is located in jiaozuo, China. By using most advanced synthesis, process and analytical equipment, the new R&D centre will highly improve our new product development and customer service capabilities.A full set of pilot manufacturing facility with capacity of 1-1,000Kg will co-work with the new R&D centre to make our internal operations more active. And it's also open to our customers for new-product development and marketing.With sustained effort on product research and development, three new products have been launched into personal care market.PiloRez hs-564: A kind of new polymer used in hair styling product. With performance of high gloss, strong adhesion & good toughness.DermaRez Protect 216 and 220: Effective waterproof agent, film forming agent & dispersant. Suitable for production of sun-protection and makeup products.Boai NKY is committed to provide high-quality products to our customers. We have been working on exploring and introducing new technology to promote our production capacity, quality management ability, as well as R&D capability. Our competitive technical team, continuous improved quality management system and perfect after-sales service have earned us customer's trust in our products.

The annual product-promotion tour of Boai NKY Pharmaceuticals Ltd. was successfully held in Malaysia & Indonesia between March, 25th~28th, 2019.Conference photograph of Boai NKY staff, conference sponsor (Narda Tita) & customer representatives-took in Indonesia.Dr. Herbert Ulmer (fifth from right), chief scientist of Boai NKY. Mr. Wojciech Bobecki (fourth from right), deputy GM of Boai NKY-Germany branch. Mr. Wang long (third from right), GM assistant of Tianjin Boai NKY international ltd., and staffs from Narda Tita.The product-promotion tour is a clear sign which shows that Boai NKY is stepping into market of Southeast Asia. We are going to focus more on customer service & technical support. Expecting to futhering cooperation with our customers on technical communication & collaborative R&D.The product-promotion tour brought our customers a deep understanding on competence of Boai NKY & quality of our products. They are looking forward to connecting with our engineers for customized solutions.Dr Herbert Ulmer, chief scientist of Boai NKY.Mr. Wang longNot only can providing high quality pharmaceutical excipients, Boai NKY also be willing to technically support our customers on regulations, supply chains, environmental protection & prodcut formula. A full set of pharmaceutical-excipients solution is what we are committed to offer.